U.S. Funding Shortfall Undermines Investment In Training Scientists

After spending $200,000 in assistance for each Ph.D., the government offers long odds to researchers setting up on their own WASHINGTON - In her youth, Patricia McGraw studied music and as a teenager was a concert pianist. These past nine years, though, she has studied science and now is an assistant professor of biological sciences at the University of Maryland Baltimore County Campus. As a pianist she worried about improving her musical prowess. As a scientist, she sometimes wonders whether

Written byElizabeth Pennisi
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


After spending $200,000 in assistance for each Ph.D., the government offers long odds to researchers setting up on their own
WASHINGTON - In her youth, Patricia McGraw studied music and as a teenager was a concert pianist. These past nine years, though, she has studied science and now is an assistant professor of biological sciences at the University of Maryland Baltimore County Campus. As a pianist she worried about improving her musical prowess. As a scientist, she sometimes wonders whether she will be able to keep practicing her profession at all.

Her education - graduate school and postdoctoral training - was financed primarily through training, fellowship, and research grants from the National Institutes of Health. Now she hopes NIH will sponsor her first experiments as an independent scientist. But for new investigators like herself, the chances of success in getting that support are much less than one in four. "Now ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies